Hypothalamic-pituitary dysfunction in patients with craniopharyngioma.
OBJECTIVE
Previous studies of preoperative pituitary function in patients with craniopharyngioma have been limited in scope and have focused on children. We have evaluated the impact of craniopharyngiomas and their surgical treatment on pituitary function in a large group of mostly adult patients.


METHODS
We performed a retrospective study of patients treated at our centre between 1980 and 1992.


METHODS
Twenty-two men and 13 women, most of them adults, treated surgically for craniopharyngioma during the above period.


METHODS
Serum glucose, GH, LH, FSH, TSH and cortisol were measured both before and after a combined insulin induced hypoglycaemia, GnRH and TRH test. Basal concentrations of thyroid hormones, PRL and gonadal steroids were also measured. Preoperative computed tomographic scan was performed in all patients, and a detailed study of visual function before and after surgery was available for 32 of them. Endocrine function was reevaluated post-operatively.


RESULTS
In preoperative studies, 29 patients had some anterior pituitary deficit and 13 had diabetes insipidus. The most common abnormality was gonadotrophin deficiency, followed by GH deficiency. Dynamic studies suggested a hypothalamic origin for these deficits. In post-surgical evaluation, impaired pituitary function was observed in most patients. Panhypopituitarism was present in 28 cases and diabetes insipidus in 24.


CONCLUSIONS
Our report illustrates the high incidence of endocrine deficits in patients with craniopharyngioma. Additional hypothalamic-pituitary dysfunction usually occurs following surgical treatment of these tumours.
Paja
M
M
Department of Endocrinology, Clínica Puerta de Hierro, Universidad Autónoma de Madrid, Spain.
Lucas
T
T
García-Uría
J
J
Salamé
F
F
Barceló
B
B
Estrada
J
J
D000293:Adolescent; D000328:Adult; D000368:Aged; D002648:Child; D002675:Child, Preschool; D003397:Craniopharyngioma / Q000097:blood / Q000503:physiopathology* / Q000601:surgery; D005260:Female; D007987:Gonadotropin-Releasing Hormone; D013006:Growth Hormone / Q000172:deficiency; D006801:Humans; D006854:Hydrocortisone / Q000097:blood; D007030:Hypothalamo-Hypophyseal System / Q000503:physiopathology*; D007986:Luteinizing Hormone / Q000378:metabolism; D008297:Male; D008875:Middle Aged; D010911:Pituitary Neoplasms / Q000097:blood / Q000503:physiopathology* / Q000601:surgery; D011184:Postoperative Period; D011388:Prolactin / Q000097:blood; D012189:Retrospective Studies; D013974:Thyroxine / Q000097:blood
D007987:Gonadotropin-Releasing Hormone; D011388:Prolactin; D007986:Luteinizing Hormone; D013006:Growth Hormone; D013974:Thyroxine; D006854:Hydrocortisone